CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY Statement - USD ($) $ in Thousands	Total	Common Stock	Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Loss	Treasury Stock	Nonredeemable Noncontrolling Interests
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cumulative adjustment from adoption of new guidance	$ 853,645	$ 814	$ 523,331	$ 1,077,747	$ (126,179)	$ (638,486)	$ 16,418
Beginning balance (in shares) at Feb. 02, 2019		81,379,660				61,327,640
Beginning balance at Feb. 02, 2019	853,645	$ 814	523,331	1,077,747	(126,179)	$ (638,486)	16,418
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cumulative adjustment from adoption of new guidance	565,078	$ 717	480,865	1,036,386	(126,179)	$ (837,705)	17,521
Net earnings (loss)	(20,581)			(21,374)			793
Other comprehensive income (loss), net of income tax	(8,198)				(8,508)		310
Issuance of common stock under stock compensation plans (in shares)		545,881				(211,221)
Issuance of common stock under stock compensation plans including tax effect	(812)	$ 5	(3,042)			$ 2,225
Issuance of stock under Employee Stock Purchase Plan (in shares)		11,377				(11,377)
Issuance of stock under Employee Stock Purchase Plan	190	$ 1	69			$ 120
Share-based compensation	4,468		4,440	28
Dividends	(18,331)			(18,331)
Share repurchases (in shares)		(10,264,052)				10,264,052
Share repurchases	(201,564)	$ (103)	103			$ (201,564)
Equity component value of convertible note issuance, net	42,324		42,324
Sale of common stock warrant	28,080		28,080
Purchase of convertible note hedge	(46,440)		(46,440)
Equity forward contract issuance	(68,000)		(68,000)
Ending balance (in shares) at May. 04, 2019		71,672,866				71,369,094
Ending balance at May. 04, 2019	565,078	$ 717	480,865	1,036,386	(132,706)	$ (837,705)	17,521
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cumulative adjustment from adoption of new guidance	565,078	717	480,865	1,036,386	(132,706)	(837,705)	17,521
Cumulative adjustment from adoption of new guidance	$ 661,347	$ 658	563,004	1,130,409	(139,910)	$ (914,447)	21,633
Beginning balance (in shares) at Feb. 01, 2020	65,848,510	65,848,510				77,019,437
Beginning balance at Feb. 01, 2020	$ 661,347	$ 658	563,004	1,130,409	(139,910)	$ (914,447)	21,633
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cumulative adjustment from adoption of new guidance	661,347	$ 676	544,319	973,006	(153,302)	$ (893,045)	15,135
Net earnings (loss)	(160,538)			(157,666)			(2,872)
Other comprehensive income (loss), net of income tax	(17,018)				(13,392)		(3,626)
Issuance of common stock under stock compensation plans (in shares)		1,763,311				(1,770,223)
Issuance of common stock under stock compensation plans including tax effect	(3,229)	$ 18	(24,264)			$ 21,017
Issuance of stock under Employee Stock Purchase Plan (in shares)		32,427				(32,427)
Issuance of stock under Employee Stock Purchase Plan	193		(192)			$ 385
Share-based compensation	5,786		5,771	15
Dividends	$ 248			248
Ending balance (in shares) at May. 02, 2020	67,644,248	67,644,248				75,216,787
Ending balance at May. 02, 2020	$ 486,789	$ 676	544,319	973,006	(153,302)	$ (893,045)	15,135
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cumulative adjustment from adoption of new guidance	$ 486,789	$ 676	$ 544,319	$ 973,006	$ (153,302)	$ (893,045)	$ 15,135